Method and composition for transdermal drug delivery

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/568 (2006.01) A61Q 90/00 (2009.01) A61K 8/63 (2006.01) A61K 9/08 (2006.01) A61K 31/57 (2006.01) A61Q 15/00 (2006.01)

Patent

CA 2610708

The invention is a transdermal drug delivery composition of at least one physiologically active agent (e.g. buspirone or fentanyl or androgens such as testosterone), at least one volatile solvent (e.g. isopropanol or ethanol), and at least one viscosity modulating agent (e.g. PVP), preferably with a penetration enhancer (such as octisalate), which is preferably applied to the axilla.

L'invention concerne une composition d'administration transdermique de médicament renfermant au moins un agent physiologiquement actif (par ex., de la buspirone ou du fentanyl ou des androgènes tels que la testostérone), au moins un solvant volatil (par ex., de l'isopropanol ou de l'éthanol), et au moins un agent modulant la viscosité (par ex., de la PVP), de préférence en combinaison avec un renforçateur de pénétration (tel que de l'octisalate), cette composition étant de préférence appliquée sur l'aisselle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method and composition for transdermal drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for transdermal drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for transdermal drug delivery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1522445

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.